Results 31 to 40 of about 1,073 (146)

Clinical profile of thyroid eye disease and factors predictive of disease severity

Indian Journal of Ophthalmology, 2020
Purpose: To describe the clinical features of thyroid eye disease (TED) in patients presenting at a tertiary eye care centre in North India and to identify factors predictive of severe disease.
Alankrita Muralidhar, Sima Das, Sweety Tiple   +2 more
doaj   +1 more source

Therapy With Intravenous Methylprednisolone Pulses Is Associated With Loss of Bone Microarchitecture in Trabecular Bone Score -Assessment Among Patients With Moderate-to-Severe Graves’ Orbitopathy: A Pilot Study

Frontiers in Endocrinology, 2022
BackgroundTherapy with intravenous glucocorticoids (GCs) is associated with various side effects, however, the impact on bone remains elusive. Trabecular bone score (TBS) is a diagnostic tool providing information on bone microarchitecture based on ...
Joanna Rymuza, Katarzyna Pelewicz, Jerzy Przedlacki, Piotr Miśkiewicz   +3 more
doaj   +1 more source

Application of Multiparameter Quantitative Magnetic Resonance Imaging in the Evaluation of Graves' Ophthalmopathy

Journal of Magnetic Resonance Imaging, Volume 58, Issue 4, Page 1279-1289, October 2023., 2023
Background Assessment of the activity of Graves' ophthalmopathy (GO) is difficult. Existing methods need improvement. Purpose Investigate the application of multiparametric magnetic resonance imaging (MRI) in GO. Study Type Retrospective. Population A total of 235 GO patients (age: 38.8 ± 13.4 years; 90 male; 96 active patients).
Zhangfang Li, Yaosheng Luo, Xiaoting Feng, Qing Zhang, Qiang Zhong, Chanyan Weng, Zhi Chen, Jie Shen   +7 more
wiley   +1 more source

The Outcomes of Balanced Orbital Decompression for Dysthyroid Optic Neuropathy: Focusing on Choroiretinal Folds with and without Optic Disc Edema

Disease Markers, Volume 2023, Issue 1, 2023., 2023
Purpose. To assess the outcomes of balanced orbital decompression for chorioretinal folds (CRFs) with and without optic disc edema (ODE) in dysthyroid optic neuropathy (DON). Method. A retrospective, interventional study was performed at Sun Yat‐sen Memorial Hospital from April 2018 to November 2021.
Peng Zeng, Xiao-wen Deng, Peng Tian, Yuan-yu Peng, Ming-tong Xu, Shi-you Zhou, Mei Wang, Gaetano Isola   +7 more
wiley   +1 more source

Assessment of risk of obstructive sleep apnea with thyroid eye disease and its activity

Indian Journal of Ophthalmology, 2023
Purpose: To evaluate the association between obstructive sleep apnea (OSA) and thyroid eye disease (TED) and its effect on disease activity. Methods: A prospective case–control study was conducted from January 2020 to March 2022.
Namita Kumari, Nitish Arora, Sima Das, Sweety Tiple, Harshdeep Singh, Narendra Patidar, Mihir Mishra, Atanu Majumdar   +7 more
doaj   +1 more source

Abstracts of the EUGOGO Global TED Forum 2025 [PDF]

Thyroid Research
doaj   +2 more sources

Repurposing picropodophyllin as a potential thyroid eye disease treatment via delaying mitotic clonal expansion through a patient‐derived preclinical platform

, 2023
Clinical and Translational Medicine, Volume 13, Issue 4, April 2023.
Jing Hu, Jiali Wu, Qihuang Jin, Ling Zhang, Ning Shen, Yiyang Shu, Lu Cheng, Jian Zhang, Guangyi Hu, Kangjia Lv, Qizhi Jian, Hui Chen, Fang Zhang, Xiaodong Sun   +13 more
wiley   +1 more source

Orbital decompression for thyroid eye disease: surgical treatment outcomes in endocrinological assessment [PDF]

, 2021
Introduction: Surgical orbital decompression involves removal of one or more of the orbital bony walls in order to gain space for overgrown muscles and adipose tissue, which results in a reduction in pressure on the eye.
Jastrzębska, Helena; Department of Endocrinology, Medical Centre of Postgraduate Education in Warsaw, Warsaw, 01-809, Poland, Krzeski, Antoni; Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Medical University of Warsaw, Warsaw, Poland, Brożek-Mądry, Eliza; Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Medical University of Warsaw, Warsaw, Poland, Jurek-Matusiak, Olga; Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Medical University of Warsaw, Warsaw, Poland, Olga Jurek-Matusiak, Helena Jastrzębska, Eliza Brożek-Mądry, Antoni Krzeski   +7 more
core   +2 more sources

Graves' orbitopathy treated with immunosuppressive therapy and orbital radiotherapy in a tertiary care endocrine centre: case series

Sri Lanka Journal of Diabetes Endocrinology and Metabolism, 2016
Graves’ Orbitopathy (GO) is a localized entity of Graves’ disease, which is a challenging disease to treat. We describe 6 cases of moderate to severe GO who presented to our endocrine centre, with a mean age of 48.6 years and equal gender distribution ...
D. C. Kottahachchi, W. K. M. G. Amarawardena, N. A. S. Ariyawansa, S. Siyambalapitiya, K. A. Perera   +4 more
doaj   +1 more source

The relation between clinical response and quality of life improvement after treatment with intravenous methylprednisolone in Graves' orbitopathy

Acta Ophthalmologica, EarlyView.
Abstract Background Quality of life (QoL) is a key outcome in Graves' orbitopathy (GO), but prior studies have reported overall QoL changes without evaluating whether improvements occur specifically in patients who achieve objective clinical response.
Gijsbert J. Hötte, Willem A. Dik, Ronald O. B. de Keizer, Sodaba Khatab, M. Medici, Sigrid M. A. Swagemakers, Peter J. van der Spek, P. Martin van Hagen, Dion Paridaens   +8 more
wiley   +1 more source